Evidence map›Paper›PMID 26043382›Full record

ReviewHematology/oncology clinics of North America2015

Complement: an overview for the clinician.

Juan Carlos Varela, Stephen Tomlinson

Open access · greenAbstract readReview
In one paragraph

Review in Hematology/oncology clinics of North America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Herbal medicines for SOD1Frontiers in immunology · 2024
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Kidney international reports · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Juan Carlos VarelaDivision of Hematology, Department of Medicine, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Stephen TomlinsonDepartment of Microbiology and Immunology, Ralph H. Johnson Veterans Affairs Medical Center, Medical University of South Carolina, Charleston, SC, USA. Electronic address: tomlinss@musc.edu.
Ralph H. Johnson VA Medical Center · USSidney Kimmel Comprehensive Cancer Center · US

Funding

Role of complement in brain death induced injury to donor heartsR01HL086576 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TOMLINSON, STEPHEN · 2007 to 2010
$1.5M
Complement, anti-tumor immunity and apoptosis-based therapyR01CA158179 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TOMLINSON, STEPHEN · 2012 to 2016
$1.5M
The Complement System and Spinal Cord InjuryI01BX001218 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI TOMLINSON, STEPHEN · 2012 to 2015
–
Novel Therapies to Improve Functional Recovery After StrokeI01RX001141 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI TOMLINSON, STEPHEN · 2014 to 2022
–
BLRD VA I01 BX001218NCI NIH HHS R01 CA158179NHLBI NIH HHS R01 HL086576RRD VA I01 RX001141
6 · The paper itself

Abstract

The complement system is an essential component of the immune system. It is a highly integrative system and has a number of functions, including host defense, removal of injured cells and debris, modulation of metabolic and regenerative processes, and regulation of adaptive immunity. Complement is activated via different pathways and it is regulated tightly by several mechanisms to prevent host injury. Imbalance between complement activation and regulation can manifest in disease and injury to self. This article provides an outline of complement activation pathways, regulatory mechanisms, and normal physiologic functions of the system.

Indexed as

Adaptive ImmunityComplement ActivationComplement System ProteinsHumansImmunity, InnateModels, ImmunologicalComplement System ProteinsComplement activationComplement functionComplement regulationComplement systemImmune responseInflammation

Identifiers

PMID26043382
PMCPMC4456616
OpenAlexW345004523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.